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A B S T R A C T
The present study was conducted to evaluate the toxicity of the ethanolic extract of leaves 
of Parkia platycephala Benth., Fabaceae, on systemic and reproductive parameters. In toxicity 
on the estrous cycle, four groups of not-pregnant Wistar rats received distilled water and the 
doses 250, 500 and 1000 mg.kg-1 of plant extract for thirty days, at the end of which they were 
examined as to the frequency of their phases. The systemic toxicity was assessed through 
the consumption of water and food and by measuring body mass. After the extract was 
administered, serum AST, ALT, ALP, bilirubin (total, direct and indirect), urea and creatinine 
were dosed. The evaluation of the organs (brain, heart, hypophysis, adrenal glands, liver, 
spleen, uterus and ovaries) in their macroscopic aspects, relative and absolute masses and 
histological structure showed that the plant extract induced a decrease of water and food 
consumption and of body mass. It caused an increase in the luteal phase and a decrease in 
the follicular phase of the estrous cycle and rose serum alkaline phosphatase levels. The data 
exhibit systemic and reproductive toxicity induced by plant extract in female Wistar rats.
© 2013 Brazilian Society of Pharmacognosy. Published by 
Elsevier Editora Ltda. 
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Introduction
According to the World Health Organization (WHO), more than 
4 billion people worldwide (or 80% of the global population) 
use medicinal plants in the primary health care (Quirish et al., 
2010). However, evidences suggest that although the adverse 
effects of using medicinal plants are less frequent than those 
from conventional drugs, scientific studies confirm that they 
exist (Haq, 2004; George, 2011). This fact was corroborated with 
the 18579 cases record of plant poisoning in Brazil, between 
1999 and 2009 (National System of Toxico-Pharmacological 
Information - Sinitox, 2011).
Parkia platycephala Benth, member of the family Fabaceae 
and popularly known as “faveira”, “faveira-preta”, “visgueira” 
and “fava-de-bolota”, is found in the mid-west, north and 
northeast, mainly in the states of Maranhão, Piaui and Ceará. Its 
pods are widely used in supplementary feeding of ruminants, 
especially sheep and cattle in the Brazilian savannah areas. 
Phytochemical analysis showed the presence of total phenols, 
flavonoids and terpenes in ethanolic extracts and fractions 
from the leaves of P. platycephala (Bezerra et al., 2009). These 
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phytochemicals may have therapeutic or toxic characteristics 
(Pandey et al., 2011). Pharmacological study from Fernandes et 
al. (2010), with P. platycephala extract, showed gastroprotective 
activity.
Given the observed therapeutic property, scientific 
research is needed to validate the effective and safe use of 
this species, enabling it in the future to become an herbal 
medicine, according to the Brazilian National Agency of 
Sanitary Vigilance’s standards. Thus, the aim of this research 
is to evaluate the possible toxicity of the ethanolic extract 
of the leaves of P. platycephala on systemic and reproductive 
parameters in Wistar female rats.
Materials and methods
Plant material and extract preparation
The collection took place in the city of Caxias-MA, in October 
2010. Representative material was sent to Graziela Barroso 
Herbarium in the Federal University of Piaui, where it was 
identified under the number 27869. The plant material 
was prepared with the leaves, which were dried in oven at 
45ºC and pulverized in an electric mill (2400 g of powder). The 
extraction was performed with ethanol by maceration for 72 h 
at room temperature in shade. The extract (EtOH-Pp) was then 
concentrated by a rotary evaporator apparatus in vacuo (50°C).
This procedure was repeated seven times with fresh solvent. 
The resulting extract was lyophilized and stored in an amber 
bottle under refrigeration (4-8°C).
The doses of EtOH-Pp used in all protocols were 250, 500 and 
1000 mg.kg-1. These doses increase in arithmetic progression 
ratio at two, trying to establish themselves the lowest dose 
that manifests toxic effects without severe damages (LOAEL) 
and obeying to limit of 1000 mg.kg-1 for toxicological tests in 
accordance with OECD 407 (OECD, 1995).
Animals
Thirty-two adult non-pregnant female Wistar rats (180-
220 g) were used in this experiment. They were raised and 
maintained in the experimental vivarium of the Department 
of Veterinary Morphophysiology (Center of Agricultural 
Sciences) at the Federal University of Piaui, Brazil. The animals 
were housed in individual standard cages, in a controlled 
temperature room (22 ± 2°C) with 12 h light/dark and free 
access to water and food (FRI-LAB Rats - Fri-Ribe). All protocols 
were carried out in accordance with the requirements of the 
Committee on Ethics Animal Experimentation in the adopted 
by the Federal University of Piaui (Protocol number: 33/2009). 
The experimental protocols were elaborated and developed 
based on the principle of the three R’s (Refine, Reduce and 
Redesign) and according to CFMV Resolution Number 714 of 
June 20th, 2002.
Estrous cycle toxicity evaluation 
The experiment consisted of four groups of eight animals each 
(n = 8) randomly divided. They were: control group, to which 
distilled water was administered, and three groups received 
EtOH-Pp 250, 500 and 1000 mg.kg-1 via the oral route (10 ml.kg-1 
of body weight) for thirty days.
The protocol used in the estrous cycle toxicity evaluation 
followed the methodology developed by Goldman et al. (2007). 
The rats were examined daily, between 8 and 9 am for seven 
days initially verify whether they were cycling normally. Only 
those with normal cycle were included in the experiment. To 
evaluate the estrous cycle, the vaginal smear was collected 
with a plastic pipette containing nearly 10 μl of saline (NaCl 0.9 
%) and deposited on a glass slide, which was observed through 
light microscopy using the objectives of 10 and 40×.
The estrous cycle phases (proestrus, estrus, metestrus and 
diestrus) used in the investigation of the influence of EtOH-Pp 
was classified according to the cellular profile of the vaginal 
smear observed in microscopy.
The determination of the estrous cycle phase frequency was 
established by the sum of the occurrences of the registered 
phases during the treatment period. The interestrus interval 
was calculated through the sum of the number of days between 
the estruses, divided by the total of days of treatment. The 
diestrus index was calculated by the sum of the numbers of 
diestrus occurrences, multiplied by 100 and divided by the days 
of treatment.
Systemic toxicity evaluation
Concomitant with the evaluation of the estrous cycle, the 
systemic toxicity of EtOH-Pp was evaluated in the same 
animals, using the method proposed by Park et al. (2010). 
Water and food consumption, body mass and biochemical 
parameters also were analysed.
Water (ml) and food (g) consumption of the animals under 
treatment was measured in each cage on the days 1, 4, 7, 10, 
13, 16, 19, 22, 25, 28 after the beginning of the treatment. These 
parameters were quantified by the difference in the amount 
available for consumption (250 ml of water and 50 g of food) on 
the day before and on the days mentioned above. 
The body mass of the animals (g) was measured on the days 
0, 1, 4, 7, 10, 13, 16, 19, 22, 25, 28 and 29 after the beginning of 
the treatment, in which day 0 represents the day before the 
first day of treatment. The animals’ body mass was registered 
also on the day after the last day of treatment (day 31).
On the day subsequent to the end of the 30 day-treatment 
with EtOH-Pp, the rats were anesthetized with an association 
of ketamine (50 mg.kg-1) and xylazine (11.5 mg.kg-1) and then 
the blood collection was proceeded through cardiac puncture, 
into the flask containing no anti-coagulant, with clot activator 
(BD- Vacuette Z serum clot activator), for the evaluation of 
biochemical parameters.
The blood samples were centrifuged at 1917 × g for 5 min and 
the serum was separated. The biochemical assays of aspartate 
aminotransferase (AST), alanine aminotransferase (ALT) and 
urea were performed through dry chemistry (Reflotron, Roche 
Diagnostics, Brazil). The alkaline phosphatase (ALP), creatinine 
(CREA), direct bilirubin (BIL D), indirect bilirubin (BIL IND) and 
total bilirubin (BIL T) assays were performed in Semi-automatic 
Biochemistry Analyzer RA-50 (Bayer), using Labtest kits (Labtest 
Diagnóstica, Lagoa Santa, MG, Brazil).
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Macroscopic aspect and organ mass measurement
After the blood collection, the rats were euthanized, using 
the same anesthetics in excess and were necropsied. Brain, 
hypophysis, adrenal glands, heart, liver, kidneys, spleen, 
ovaries and uterus were dissected and macroscopically 
evaluated for color and morphology. Also there was a 
measurement of the organs’ absolute masses and relative 
masses according to brain weight. The material was fixed in 
a buffered 10% formalin solution until the histopathological 
processing procedures.
Histopathological analysis
After the fixation of the organs, their fragments were 
dehydrated in alcohol solutions of increasing concentrations; 
diafanized in xylol; included in paraffin, CUT at μm, colored 
by hematoxylin-eosin and examined under a light microscope.
Statistical analysis
 The numerical results were evaluated through variance 
analysis, followed by the Tukey test at 5% to compare the 
means. The data were presented mean ± SEM. Statistical 
analyses were performed using GraphPad Prism version 5.00 
(GraphPad, San Diego, CA, USA).
Results
The Pp-EtOH extract toxicity in the estrous cycle demonstrated 
that proestrus frequency was significantly reduced at doses of 
500 and 1000 mg.kg-1 compared to vehicle. The frequency of 
the other phases, as well as the interestrus interval, was not 
significantly altered (Table 1).
The water and food consumption were significantly reduced 
between the doses of 500 and 1000 mg.kg-1 vs. vehicle and in 
the dose of 250 mg.kg-1, there was a reduction in the water 
consumption. Although, the difference among the doses was 
not significant, there was a significant reduction in body 
mass in the doses of 500 and 1000 mg.kg-1 of EtOH-Pp when 
compared to vehicle (Table 2).
Increased ALP enzyme dosages in the doses of 500 and 
1000 mg.kg-1 compared to vehicle, while the other biochemical 
parameters did not show significant alteration, those 
presented in Table 3. The macroscopic analysis of the heart, 
brain, hypophysis, adrenal glands, liver, kidneys, ovaries and 
uterus did not demonstrate morphologic alterations among 
the groups (results not shown).
Among the organs analyzed, the uterus had significant 
reduction in its relative mass at the doses of 250, 500 and 1000 
mg.kg-1 (Table 4). There were no significant alterations in the 
relative weight of the other organs evaluated.
Regarding histopathological analysis, heart, brain, liver, kidneys, 
uterus and ovaries did not demonstrate significant alteration in the 
groups treated with extract, compared to vehicle (data not shown).
Discussion
Several potentially active substances were described in 
Pp-EtOH extract, such as phenolics compounds, flavonoids 
and triterpenes (Bezerra et al., 2009). Besides these, other 
substances such as steroids, tannins, saponins, cardiac 
glycosides have been found in the genus Parkia according 
Phase
Frequency
Treatments
Vehicle
(H20d)
EtOH-Pp
250 mg.kg-1
EtOH-Pp
500 mg.kg-1
EtOH-Pp
1000 mg.kg-1
Proestrus 7.375 ± 0.263 6.750 ± 0.250 5.500 ± 0.423
a 5.750 ± 0.313a
Estrus 7.375 ± 0.324 7.125 ± 0.350 6.750 ± 0.453 6.500 ± 0.500
Interestrus
Interval
4.093 ± 0.194 4.423 ± 0.316 4.775 ± 0.293 5.068 ± 0.525
Metaestrus 8.125 ± 0.549 8.000 ± 0.423 7.750 ± 0.366 7.375 ± 0.375
Diestrus 8.125 ± 0.295 9.125 ± 0.895 11.000 ± 0.707a 11.375 ± 0.90a
Diestrus index (%) 26.200 29.438 30.587 38.338a
Diestrus index, Number of days with clear diestrus smear × 100/total duration of treatment (days).The data represent the mean ± SEM animals,  
n = 8. 
 a p < 0.05 vs. vehicle. 
Table 1
Frequency of estrus cycle phases, interval between estrus and diestrus index after 30 days of treatment with different doses of 
ethanolic extract of Parkia platycephala (EtOH-Pp). 
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Ajaiyeoba (2002) and could be responsible for therapeutic 
or toxic activities on reproductive and systemic parameters. 
There are no records of studies on systemic and reproductive 
toxicity of Parkia platycephala Benth. Thus, this study about 
the EtOH-Pp aimed to establishing doses note possible toxic 
effects over systemic and reproductive parameters in non-
pregnant rats. 
The short length of the estrous cycle of rats makes them 
ideal for investigation of changes occurring during the 
Parameters
Consumption
Treatments
Vehicle
(H2O)
EtOH-Pp
250 mg.kg-1
EtOH-Pp
500 mg.kg-1
EtOH-Pp
1000 mg.kg-1
Water (ml) 24.930 ± 1.215 22.130 ± 0.886 
a 20.830 ± 0.493a 23.800 ± 1.201a
Food (g) 14.750 ± 0.307 13.200 ± 0.401 11.92 0 ± 0.545
a 12.310 ± 0.438a
The data represent the mean ± standard error of the mean of animals, n = 8. 
ap < 0.05 vs. vehicle.
Table 2
Water and food consumption by female rats during 30 days of treatment with ethanol extract from leaves of Parkia platycephala 
Benth (Pp-EtOH) at different doses.
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Serum concentrations
Treatments
Vehicle
(H20d)
EtOH-Pp
250 mg.kg-1
EtOH-Pp
500 mg.kg-1
EtOH-Pp
1000 mg.kg-1
AST 76 - 100 60.633 ± 2.082 74.417 ± 5.901 65.167 ± 3.832 69.400 ± 2.440
ALT 45 - 61 34.967 ± 1.684 37.883 ± 3.694 34.850 ± 3.296 28.933 ± 3.017
ALP 57 - 61 39.250 ± 5.799 68.375 ± 10.765 90.500 ± 13.639 
a 89.500 ± 4.668a
BIL D - 0.225 ± 0.056 0.163 ± 0.026 0.188 ± 0.040 0.200 ± 0.038
BIL IND - 0.575 ± 0.121 0.638 ± 0.096 0.712 ± 0.074 0.675 ± 0.080
BIL T - 0.800 ± 0.093 0.925 ± 0.136 1.000 ± 0.127 0.875 ± 0.077
UREA 52 - 62 47.750 ± 1.968 48.225 ± 1.009 44.187 ± 2.137 43.513 ± 1.160
CREA 0.4 - 0.6 0.375 ± 0.065 0.325 ± 0.031 0.400 ± 0.033 0.388 ± 0.030
The data represent the mean ± standard error of mean, n = 8. 
a p < 0.05 vs. vehicle.
Table 3
Serum concentrations of aspartate transferase (AST), alanine transferase (ALT) and alkaline phosphatase (ALP) in U/l, direct 
bilirubin (BIL D), bilirubin (BIL IND), total bilirubin (T-BIL), urea, creatinine (CREA) in mg.dl-1 in female rats after 30 days´ 
administration of ethanol extract from leaves of Parkia platycephala (Pp-EtOH) at different doses.
reproductive cycle (Marcondes et al., 2002). The results 
of the estrous cycle evaluation demonstrate the probable 
reproductive toxicity of EtOH-Pp in the doses of 500 and 
1000 mg.kg-1, for it has altered the frequency of the phases 
of estrous cycle diestrus prolongation and reduction of 
proestrus, as suggested in Goldman et al. (2007). This 
is similar to reports from Soni et al. (2013) wherein the 
treatment of rats with ethanol extract of stem of Musa 
paradisiaca L., Musaceae, at doses of 250 and 500 mg.kg-1 
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Organ
Relative mass of the organs (g/100 g of body mass)
Treatments
Vehicle
(H20)
EtOH-Pp
250 mg.kg-1
EtOH-Pp
500 mg.kg-1
EtOH-Pp
1000 mg.kg-1
Brain 0.872 ± 0.031 0,884 ± 0.034 0,907 ± 0.027 0,953 ± 0.025
Hypophysis 0.06 ± 0.0007 0.006 ± 0.001 0.013 ± 0.008 0.006 ± 0.0006
Adrenal 0.019 ± 0.002 0.016 ± 0.002 0.016 ± 0.002 0.018 ± 0.0009
Liver 2.846 ± 0.107 2.698 ± 0.011 2.741 ± 0.096 2.750 ± 0.076
Kidneys 0.346 ± 0.008 0.353 ± 0.007 0.347 ± 0.010 0.336 ± 0.009
Spleen 0.325 ± 0.021 0.332 ± 0.016 0.331 ± 0.010 0.323 ± 0.015
Heart 0.380 ± 0.008 0.403 ± 0.021 0.365 ± 0.007 0.357 ± 0.011
Uterus 0.492 ± 0.057 0.229 ± 0.009a 0.253 ± 0.024a 0.287 ± 0.025a
Ovary 0.028 ± 0.020 0.026 ± 0.002 0.055 ± 0.029 0.034 ± 0.003
The data represent the mean ± standard error of the mean of animals, n = 8. 
a p < 0.05 vs. vehicle.
Table 4
Relative mass of the organs of rats relative body mass (g/100 g body weight) after 30 days of exposure to different doses of the 
extract of Parkia platycephala (EtOH-Pp).
body weight for five days caused a prolonged diestrous stage 
of the estrous cycle.
These alterations can be explained possibly by the 
presence of progestogen in EtOH-Pp, capable of inhibiting the 
hypothalamic-pituitary axis and the follicular development, 
similar to what was observed by Bakry et al. (2010) in a 
treatment of mice with medroxyprogesterone acetate. Those 
substances can be among the steroid compounds described 
in the extract of plant of the same genus in the study of 
Ajaiyeoba (2002). This effect similar to the progestogen’s 
must be investigated for the possibility of provoking anestrus 
in farm animals that ordinarily ingest the pods of the plant, 
and also for the potential use in phytotherapy.
The decrease in water consumption in the EtOH-Pp 
doses used can be explained by the presence of phenolic 
compounds, as described by Bezerra et al. (2009). These 
compounds reduce water ingest by altering the palatability 
and not for their direct toxic effects, as it could be inferred. 
Besides water consumption, also there was a reduction 
in food ingest and body mass. A possible explanation 
for the decrease in food ingest concerns alterations in 
gastrointestinal hormones like glucagon and pancreatic 
polypeptide, which act like neurotransmitters in the central 
nervous system, peripheral action by specific receptors in 
glucagon like receptors (GCGR) and Y2, respectively (Suzuki 
et al., 2010).
The biochemical to the analysis, there were no significant 
alterations in AST, ALT enzymes dosages. Also, serum values 
below the reference range show absence of hepatotoxicity of 
EtOH-Pp, according to Mukinda and Syce´s (2007) acute and 
chronic toxicity study of Artemisia afra in rats and Oluduro 
and Aderiye (2009), who evaluated the effects of Moringa 
oleifera extract in albino rats. This fact was also corroborated 
with the total, direct and indirect bilirubin dosages, which 
also did not demonstrate significant differences.
Nevertheless, the high levels of alkaline phosphatase in 
the doses of 500 and 1000 mg.kg-1 seem not to be due to 
EtOH-Pp toxicity with hepatic injury, because the enzymes 
AST and ALT did not suffer significant alterations, but 
they can be related to the skeletal muscle metabolism 
disturbance, according to Amida et al. (2007), in a study of 
acute and chronic toxicity of Artemisia afra in rats or bone 
alteration, as in Oluduro and Aderiye´s (2009) analysis of 
the effect of Moringa oleifera extract on enzymes’ activity in 
albino rats.
In urea and creatinine serum concentrations, there was 
no significant difference among the treated groups; also, 
their values were below the reference range, what implies 
that EtOH-Pp is not toxic to the kidneys. The macroscopic 
analysis, like the histopathological analysis of the heart, 
brain, liver, ovaries, and uterus of rats after exposure to 
different doses of EtOH-Pp, did not demonstrate significant 
alterations in their color, morphology and macroscopic 
structures, what evidences the extract incapacity to induce 
structural alterations in these organs.
In the analysis of the weight of the organs, both the 
absolute and the one related to the brain weight, there 
was only significant reduction in the uterus compared to 
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vehicle, in the doses of 250, 500 and 1000 mg.kg-1, what 
demonstrates the toxic effect of EtOH-Pp on uterus. 
According to Wolfsegger et al. (2009), the weight alteration 
can indicate direct toxic effect of an extract on an organ 
even in the absence of morphological changes in the organ. 
Thus, EtOH-Pp presents evidence of direct toxicity on the 
uterus.
The fact that the reduction of uterine weight repeats 
both in the absolute measurements as well as in the ones 
related to the brain weight corroborates also the possibility 
of toxic effect of EtOH-Pp, especially because as in Bailey et 
al. (2004), brain weight does not usually suffer from chemical 
substance influence. Another possible mechanism that could 
explain the decrease in uterine weight is the presence of 
substances with antiestrognic activity in EtOH-Pp, which 
can reduce the effect of endogenous estrogens, like in 
a study on the effects of the species Nelumbo nucífera on 
reproductive organs developed by Mutreja et al. (2008), 
neutralizing their proliferative effects on the uterus. These 
substances can be flavonoids, compounds possibly present 
in EtOH-Pp in previous work (Bezerra et. al., 2009), that can 
present antiestrogenic action through a mechanism that is 
independent and dependent on estrogen receptor (Collins-
Burow et al. 2000).
Briefly, the extract induced more toxicity on water and 
food consumption, body mass, and an increase in the 
biochemical parameter of bone alteration, in the dose of 
1000 mg.kg-1. Regarding the great organs of blood flow 
and the biochemical blood parameters, the extract did 
not produce structural and biochemical alterations that 
indicate functional alteration in the organs evaluated. In 
reproductive toxicity, the EtOH-Pp extract, in the highest 
dose, demonstrated toxicity on estrous cycle with increase 
in the diestrus phase ratio and reduction of the uterus 
weight.
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